GB0703514D0 - Use of riboflavin - Google Patents

Use of riboflavin

Info

Publication number
GB0703514D0
GB0703514D0 GBGB0703514.0A GB0703514A GB0703514D0 GB 0703514 D0 GB0703514 D0 GB 0703514D0 GB 0703514 A GB0703514 A GB 0703514A GB 0703514 D0 GB0703514 D0 GB 0703514D0
Authority
GB
United Kingdom
Prior art keywords
riboflavin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0703514.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altnagelvin Hospital H & Ss Tr
TRINITY OF QUEEN ELIZABETH
Ulster University
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Original Assignee
Altnagelvin Hospital H & Ss Tr
TRINITY OF QUEEN ELIZABETH
Ulster University
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altnagelvin Hospital H & Ss Tr, TRINITY OF QUEEN ELIZABETH, Ulster University, College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin filed Critical Altnagelvin Hospital H & Ss Tr
Priority to GBGB0703514.0A priority Critical patent/GB0703514D0/en
Publication of GB0703514D0 publication Critical patent/GB0703514D0/en
Priority to US12/528,105 priority patent/US20100324019A1/en
Priority to CA2679217A priority patent/CA2679217C/en
Priority to MX2009009020A priority patent/MX2009009020A/es
Priority to CN2008800135209A priority patent/CN101678030B/zh
Priority to EP08715988A priority patent/EP2139488B1/en
Priority to PCT/EP2008/001437 priority patent/WO2008101724A1/en
Priority to JP2009550246A priority patent/JP5577100B2/ja
Priority to ES08715988T priority patent/ES2393144T3/es
Priority to EA200901145A priority patent/EA019281B1/ru
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0703514.0A 2007-02-23 2007-02-23 Use of riboflavin Ceased GB0703514D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB0703514.0A GB0703514D0 (en) 2007-02-23 2007-02-23 Use of riboflavin
EA200901145A EA019281B1 (ru) 2007-02-23 2008-02-22 Применение рибофлавина в лечении гипертензии
CN2008800135209A CN101678030B (zh) 2007-02-23 2008-02-22 核黄素在治疗高血压中的用途
CA2679217A CA2679217C (en) 2007-02-23 2008-02-22 Use of riboflavin in the treatment of hypertension
MX2009009020A MX2009009020A (es) 2007-02-23 2008-02-22 Uso de riboflavina en el tratamiento de la hipertension.
US12/528,105 US20100324019A1 (en) 2007-02-23 2008-02-22 Use of Riboflavin in the Treatment of Hypertension
EP08715988A EP2139488B1 (en) 2007-02-23 2008-02-22 Use of riboflavin in the treatment of hypertension
PCT/EP2008/001437 WO2008101724A1 (en) 2007-02-23 2008-02-22 Use of riboflavin in the treatment of hypertension
JP2009550246A JP5577100B2 (ja) 2007-02-23 2008-02-22 高血圧症治療におけるリボフラビンの使用
ES08715988T ES2393144T3 (es) 2007-02-23 2008-02-22 Uso de riboflavina en el tratamiento de la hipertensión

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0703514.0A GB0703514D0 (en) 2007-02-23 2007-02-23 Use of riboflavin

Publications (1)

Publication Number Publication Date
GB0703514D0 true GB0703514D0 (en) 2007-04-04

Family

ID=37945596

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0703514.0A Ceased GB0703514D0 (en) 2007-02-23 2007-02-23 Use of riboflavin

Country Status (10)

Country Link
US (1) US20100324019A1 (enExample)
EP (1) EP2139488B1 (enExample)
JP (1) JP5577100B2 (enExample)
CN (1) CN101678030B (enExample)
CA (1) CA2679217C (enExample)
EA (1) EA019281B1 (enExample)
ES (1) ES2393144T3 (enExample)
GB (1) GB0703514D0 (enExample)
MX (1) MX2009009020A (enExample)
WO (1) WO2008101724A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104737023B (zh) * 2012-08-16 2017-07-28 重症监护诊断股份有限公司 预测患高血压风险的方法
CN103721259A (zh) * 2014-01-07 2014-04-16 深圳奥萨医药有限公司 血管紧张素ⅱ受体阻断剂/噻嗪类利尿剂/5-甲基四氢叶酸药物组合物
CN109295216A (zh) * 2018-11-06 2019-02-01 宁波艾捷康宁生物科技有限公司 预测高血压个体化药物药效的snp位点和检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264601A (en) * 1979-06-12 1981-04-28 The Board Of Regents Of The University Of Oklahoma Antihypertensive agents and their use in treatment of hypertension
DE3682208D1 (de) * 1986-12-18 1991-11-28 Kurt Heinz Bauer Gegenueber lichteinfluss stabilisiertes nifedipin-konzentrat und verfahren zu seiner herstellung.
US6485959B1 (en) * 1998-10-07 2002-11-26 Cedars Sinai Medical Center Cell preconditioning and cryopresevation medium
CN1136895C (zh) * 2001-05-24 2004-02-04 魏振鸣 一种治疗冠心病的药物
WO2006085128A1 (en) * 2005-02-09 2006-08-17 Wockhardt Limited Cardiovascular therapeutic combinations
US7838526B2 (en) * 2005-08-05 2010-11-23 Esther Baldinger Method of treating neurological disorders

Also Published As

Publication number Publication date
US20100324019A1 (en) 2010-12-23
CA2679217A1 (en) 2008-08-28
EP2139488A1 (en) 2010-01-06
EA019281B1 (ru) 2014-02-28
CN101678030B (zh) 2013-06-05
EP2139488B1 (en) 2012-08-15
CN101678030A (zh) 2010-03-24
WO2008101724A1 (en) 2008-08-28
EA200901145A1 (ru) 2010-02-26
JP2010519235A (ja) 2010-06-03
WO2008101724A8 (en) 2009-10-08
MX2009009020A (es) 2010-02-17
CA2679217C (en) 2016-05-17
JP5577100B2 (ja) 2014-08-20
ES2393144T3 (es) 2012-12-18

Similar Documents

Publication Publication Date Title
GB0701426D0 (en) Compounds and their use
IL211549A0 (en) Aminotriazolopyridines and their use as kinase inhibitors
GB0818241D0 (en) Compounds and their use
GB0700580D0 (en) Use
PL2344449T3 (pl) Związki arylo-fenylo-sulfonamido-cykloalkilowe i ich zastosowanie
IL208081A0 (en) Amido - thiophene compounds and their use
ZA201007395B (en) Aryl-quinolyl compounds and their use
GB0714670D0 (en) Use
GB0712503D0 (en) Use
PL2328545T3 (pl) Zastosowanie glukozyloglicerolu
IL208771A0 (en) Iminopyridine derivatives and use thereof
GB0812012D0 (en) Use
IL199765A0 (en) Use of tocopherol
PL2237782T3 (pl) Zastosowanie tetrahydropirymidyn
GB0703514D0 (en) Use of riboflavin
GB0801319D0 (en) Compounds and their use
GB201114396D0 (en) Location of basesation
GB0807621D0 (en) Use
GB0702555D0 (en) An article of footwaear
ZA201000371B (en) Article of jewelerry
GB0701096D0 (en) Use
GB0705204D0 (en) Uses of (S)-clenbuterol
GB0703144D0 (en) Use of Neon
GB0817897D0 (en) Compounds and their use
GB0802194D0 (en) Compounds and their use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)